Why is Colinz Labs falling/rising?

As of 21-Jul, Colinz Laboratories Ltd's stock price is currently at Rs 53.82, reflecting an increase of 2.56 (4.99%). The stock has been on a positive trajectory, gaining for the last eight days and achieving a remarkable 39.29% return during this period. It opened today with a gain of 4.99% and reached an intraday high of Rs 53.82. However, despite this recent uptick, the stock has a weak long-term fundamental strength, evidenced by a -2.96% CAGR growth in net sales over the last five years and a low return on equity of 4.40%. Additionally, the company has struggled with debt servicing, indicated by a poor EBIT to interest ratio of 0.36, which may contribute to investor caution.
In the broader market context, Colinz Laboratories has significantly outperformed the Sensex over the past week, with a return of +27.57% compared to the benchmark's -0.06%. However, over the longer term, the stock has underperformed, with a year-to-date decline of -22.85% against the Sensex's +5.20%. This disparity highlights the stock's volatility and potential investor concerns regarding its long-term viability, despite recent short-term gains. The stock's liquidity appears adequate for trading, but falling investor participation, as indicated by a 30.01% drop in delivery volume, may signal waning interest among investors.